262 related articles for article (PubMed ID: 33666217)
41. Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate.
Posor Y; Eichhorn-Gruenig M; Puchkov D; Schöneberg J; Ullrich A; Lampe A; Müller R; Zarbakhsh S; Gulluni F; Hirsch E; Krauss M; Schultz C; Schmoranzer J; Noé F; Haucke V
Nature; 2013 Jul; 499(7457):233-7. PubMed ID: 23823722
[TBL] [Abstract][Full Text] [Related]
42. Down-regulation of class II phosphoinositide 3-kinase alpha expression below a critical threshold induces apoptotic cell death.
Elis W; Triantafellow E; Wolters NM; Sian KR; Caponigro G; Borawski J; Gaither LA; Murphy LO; Finan PM; Mackeigan JP
Mol Cancer Res; 2008 Apr; 6(4):614-23. PubMed ID: 18403640
[TBL] [Abstract][Full Text] [Related]
43. The class II phosphoinositide 3-kinase C2alpha is activated by clathrin and regulates clathrin-mediated membrane trafficking.
Gaidarov I; Smith ME; Domin J; Keen JH
Mol Cell; 2001 Feb; 7(2):443-9. PubMed ID: 11239472
[TBL] [Abstract][Full Text] [Related]
44. Kaposi's Sarcoma-Associated Herpesvirus Nonstructural Membrane Protein pK15 Recruits the Class II Phosphatidylinositol 3-Kinase PI3K-C2α To Activate Productive Viral Replication.
Abere B; Samarina N; Gramolelli S; Rückert J; Gerold G; Pich A; Schulz TF
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950425
[TBL] [Abstract][Full Text] [Related]
45. Are class II phosphoinositide 3-kinases potential targets for anticancer therapies?
Traer CJ; Foster FM; Abraham SM; Fry MJ
Bull Cancer; 2006 May; 93(5):E53-8. PubMed ID: 16777618
[TBL] [Abstract][Full Text] [Related]
46. [Phosphoinositides: lipidic essential actors in the intracellular traffic].
Bertazzi DL; De Craene JO; Bär S; Sanjuan-Vazquez M; Raess MA; Friant S
Biol Aujourdhui; 2015; 209(1):97-109. PubMed ID: 26115715
[TBL] [Abstract][Full Text] [Related]
47. Suppression of the alpha-isoform of class II phosphoinositide 3-kinase gene expression leads to apoptotic cell death.
Kang S; Song J; Kang J; Kang H; Lee D; Lee Y; Park D
Biochem Biophys Res Commun; 2005 Apr; 329(1):6-10. PubMed ID: 15721265
[TBL] [Abstract][Full Text] [Related]
48. Risk1, a Phosphatidylinositol 3-Kinase Effector, Promotes Rickettsia typhi Intracellular Survival.
Voss OH; Gillespie JJ; Lehman SS; Rennoll SA; Beier-Sexton M; Rahman MS; Azad AF
mBio; 2020 Jun; 11(3):. PubMed ID: 32546622
[TBL] [Abstract][Full Text] [Related]
49. Involvement of class II phosphoinositide 3-kinase α-isoform in antigen-induced degranulation in RBL-2H3 cells.
Nigorikawa K; Hazeki K; Guo Y; Hazeki O
PLoS One; 2014; 9(10):e111698. PubMed ID: 25357130
[TBL] [Abstract][Full Text] [Related]
50. The Isoform Selective Roles of PI3Ks in Dendritic Cell Biology and Function.
Aksoy E; Saveanu L; Manoury B
Front Immunol; 2018; 9():2574. PubMed ID: 30498491
[TBL] [Abstract][Full Text] [Related]
51. The lipid products of phosphoinositide 3-kinase isoforms in cancer and thrombosis.
Anquetil T; Payrastre B; Gratacap MP; Viaud J
Cancer Metastasis Rev; 2018 Sep; 37(2-3):477-489. PubMed ID: 29868934
[TBL] [Abstract][Full Text] [Related]
52. Sevoflurane and isoflurane inhibit KCl-induced Class II phosphoinositide 3-kinase α subunit mediated vasoconstriction in rat aorta.
Yang S; Wu Q; Huang S; Wang Z; Qi F
BMC Anesthesiol; 2016 Aug; 16(1):63. PubMed ID: 27538808
[TBL] [Abstract][Full Text] [Related]
53. Downregulation of class II phosphoinositide 3-kinase PI3K-C2β delays cell division and potentiates the effect of docetaxel on cancer cell growth.
Cisse O; Quraishi M; Gulluni F; Guffanti F; Mavrommati I; Suthanthirakumaran M; Oh LCR; Schlatter JN; Sarvananthan A; Broggini M; Hirsch E; Falasca M; Maffucci T
J Exp Clin Cancer Res; 2019 Nov; 38(1):472. PubMed ID: 31752944
[TBL] [Abstract][Full Text] [Related]
54. A differential role for endocytosis in receptor-mediated activation of Nox1.
Miller FJ; Chu X; Stanic B; Tian X; Sharma RV; Davisson RL; Lamb FS
Antioxid Redox Signal; 2010 Mar; 12(5):583-93. PubMed ID: 19737091
[TBL] [Abstract][Full Text] [Related]
55. Targeting Class I-II-III PI3Ks in Cancer Therapy: Recent Advances in Tumor Biology and Preclinical Research.
Thibault B; Ramos-Delgado F; Guillermet-Guibert J
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765741
[TBL] [Abstract][Full Text] [Related]
56. Rethinking phosphatidylinositol 3-monophosphate.
Falasca M; Maffucci T
Biochim Biophys Acta; 2009 Dec; 1793(12):1795-803. PubMed ID: 19852987
[TBL] [Abstract][Full Text] [Related]
57. Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macroautophagy in HT-29 cells.
Petiot A; Ogier-Denis E; Blommaart EF; Meijer AJ; Codogno P
J Biol Chem; 2000 Jan; 275(2):992-8. PubMed ID: 10625637
[TBL] [Abstract][Full Text] [Related]
58. Endothelial PI3K-C2α, a class II PI3K, has an essential role in angiogenesis and vascular barrier function.
Yoshioka K; Yoshida K; Cui H; Wakayama T; Takuwa N; Okamoto Y; Du W; Qi X; Asanuma K; Sugihara K; Aki S; Miyazawa H; Biswas K; Nagakura C; Ueno M; Iseki S; Schwartz RJ; Okamoto H; Sasaki T; Matsui O; Asano M; Adams RH; Takakura N; Takuwa Y
Nat Med; 2012 Oct; 18(10):1560-9. PubMed ID: 22983395
[TBL] [Abstract][Full Text] [Related]
59. Insulin-feedback via PI3K-C2alpha activated PKBalpha/Akt1 is required for glucose-stimulated insulin secretion.
Leibiger B; Moede T; Uhles S; Barker CJ; Creveaux M; Domin J; Berggren PO; Leibiger IB
FASEB J; 2010 Jun; 24(6):1824-37. PubMed ID: 20061534
[TBL] [Abstract][Full Text] [Related]
60. The emerging mechanisms of isoform-specific PI3K signalling.
Vanhaesebroeck B; Guillermet-Guibert J; Graupera M; Bilanges B
Nat Rev Mol Cell Biol; 2010 May; 11(5):329-41. PubMed ID: 20379207
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
